(Q44551764)

4 December 2017

title

Long-term sertraline treatment and peripheral biochemical markers in female depressed patients (English)

1 reference

4 December 2017

1 reference

1

1 reference

4 December 2017

Dorotea Mück-Seler

2

1 reference

4 December 2017

Marina Sagud

3

1 reference

4 December 2017

Miro Jakovljević

4

1 reference

4 December 2017

Maja Mustapić

5

1 reference

4 December 2017

Alma Mihaljević-Peles

6

1 reference

4 December 2017

publication date

1 August 2003

1 reference

Progress in Neuro-Psychopharmacology & Biological Psychiatry

4 December 2017

published in

1 reference

4 December 2017

volume

27

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

759-765

1 reference

Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: Effects of clomipramine and fluoxetine

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Human brain cortex and platelet serotonin2 receptor binding properties and their regulation by endogenous serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Sertraline pharmacokinetics and dynamics in adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

The platelet serotonergic system in depression and following sertraline treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Platelets and psychiatry: lessons learned from old and new studies

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Prediction of response to nortriptyline and phenelzine by platelet MAO activity

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Neurochemistry and paroxetine response in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Platelet serotonin content and plasma tryptophan in peri- and postmenopausal women: variations with plasma oestrogen levels and depressive symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Seasonal influence on platelet 5-HT levels in patients with recurrent major depression and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Reduction of platelet serotonin content in depressed patients treated with either paroxetine or desipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Sertraline versus imipramine to prevent relapse in chronic depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

A rapid microfluorimetric determination of monoamine oxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

A randomized trial of a specific adherence enhancement program in sertraline-treated adults with major depressive disorder in a primary care setting

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Effects of the menstrual cycle on dependent variables in mood disorder research

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Biological parameters in major depression: effects of paroxetine, viloxazine, moclobemide, and electroconvulsive therapy. Relation to early clinical outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentation

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

The spectrum of behaviors influenced by serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Effect of antidepressant treatment on platelet 5-HT content and relation to therapeutic outcome in unipolar depressive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Platelet 5-HT concentrations and suicidal behaviour in recurrent major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Effect of age on platelet 5-HT concentrations in healthy controls, depressed and schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Sex differences, season of birth and platelet 5-HT levels in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Smoking only explains part of the associations between platelet monoamine oxidase activity and personality

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Effects of the antidepressant drug tianeptine on plasma and platelet serotonin of depressive patients and healthy controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Kinetics of the interaction of sertraline with the human platelet plasma membrane 5-hydroxytryptamine carrier

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Hypothalamic-pituitary-adrenal axis function and platelet serotonin concentrations in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Platelet serotonin concentration in dialysis patients with somatic symptoms of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Suicidal behavior, impulsiveness and serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Effects of sertraline treatment on plasma cortisol, prolactin and thyroid hormones in female depressed patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Decreased plasma serotonin in melancholic patients: A study with clomipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Tryptophan hydroxylase gene associated with paroxetine antidepressant activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Why settle for silver, when you can go for gold? Response vs. recovery as the goal of antidepressant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Serotonergic function in major depression and effect of sertraline and paroxetine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Is there a relationship between baseline and treatment-associated changes in [3H]-IMI platelet binding and clinical response in major depression?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Platelet serotonin, monoamine oxidase activity, and [3H]paroxetine binding related to impulsive suicide attempts and borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Clinical Implications of the Pharmacology of Sertraline

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

Monoamine oxidase: associations with alcohol dependence, smoking and other measures of psychopathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900105-2

7 January 2021

10.1016/S0278-5846(03)00105-2

Identifiers

DOI

1 reference

4 December 2017

1 reference